Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Simon Daniel Van Haren"'
Autor:
David J. Dowling, Holly Sanders, Wing Ki Cheng, Sweta Joshi, Spencer Brightman, Ilana Bergelson, Carlo Pietrasanta, Simon Daniel Van Haren, Sandra van Amsterdam, Jeffrey Fernandez, Germie P.J.M. van den Dobbelsteen, Ofer Levy
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Background. Group B Neisseria meningitidis, an endotoxin-producing gram-negative bacterium, causes the highest incidence of group B meningococcus (MenB) disease in the first year of life. The Bexsero vaccine is indicated in Europe from 8 weeks of age
Externí odkaz:
https://doaj.org/article/429d5895912a45e697300e6c6b16774e
Autor:
Dheeraj Soni, Francesco Borriello, David A Scott, Al Ozonoff, Spencer Brightman, Jennifer Smith, Caroline Shamu, Juan C Ramirez, Lindsey Robert Baden, Wing Ki Cheng, Simon Daniel van Haren, Matthew Pettengill, David J Dowling, Ofer Levy
Publikováno v:
The Journal of Immunology. 204:166.19-166.19
Infection is a significant cause of mortality and immunization is the most promising biomedical intervention to reduce this burden. However, multiple booster doses are often required to protect those with distinct immunity such as the young, elders,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92c78228f91efaea5e3e131a07df1d68
https://doi.org/10.4049/jimmunol.204.supp.166.19
https://doi.org/10.4049/jimmunol.204.supp.166.19
Autor:
Asimenia Angelidou, Joann Diray-Arce, Maria Giulia Conti, Kinga K. Smolen, Simon Daniël van Haren, David J. Dowling, Robert N. Husson, Ofer Levy
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Vaccines have been traditionally developed with the presumption that they exert identical immunogenicity regardless of target population and that they provide protection solely against their target pathogen. However, it is increasingly appreciated th
Externí odkaz:
https://doaj.org/article/aaad273a53b14225bf99a23e22d83383